Pharmacologic treatment of schizophrenia
Open Access
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 46 (10), 1396-1408
- https://doi.org/10.1016/s0006-3223(99)00059-1
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophreniaBiological Psychiatry, 1999
- Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind StudyAmerican Journal of Psychiatry, 1998
- Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidolSchizophrenia Research, 1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Association between clozapine response and allelic variation in 5-HT2A receptor geneThe Lancet, 1995
- Patient response and resource management: another view of clozapine treatment of schizophreniaAmerican Journal of Psychiatry, 1995
- Decreased substance use in chronically psychotic patients treated with clozapineAmerican Journal of Psychiatry, 1994
- Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapyAmerican Journal of Psychiatry, 1994
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994